New RCP report reveals more mesothelioma patients are receiving active treatment

New RCP report reveals more mesothelioma patients are receiving active treatment

New report reveals more mesothelioma patients are receiving active treatment

A new report from the Royal College of Physicians (RCP) and Mesothelioma UK shows that more mesothelioma patients diagnosed in England and Wales during 2014-2016 are receiving active anti-cancer treatment with chemotherapy.

The report also shows that despite increased active treatment, just 7% of patients are alive three years after being diagnosed.

Mesothelioma is a type of cancer predominately linked to asbestos, and found mainly in older men due to being linked to occupations such as shipbuilding and electrical installation where exposure to asbestos is high. The disease typically affects the chest, but can also occur in other sites such as the abdomen.

Other key findings from the National Mesothelioma Audit report 2018 include:

  • Pathological confirmation of the diagnosis was achieved in 88% of cases, only just short of the 90% audit standard
  • Access to a cancer nurse specialist remains variable across England.
  • 81% of patients were discussed at lung multi-disciplinary team (MDTs) meetings – short of the 95% target but an improvement on previous years
  • Specialist services for patients suffering from peritoneal mesothelioma are now emerging. Peritoneal mesothelioma is rare, constituting 4% of mesothelioma cases, and are included for the first time in this report

Download the National Mesothelioma Audit Report 2018 here

Thanks to all our Partner organisations


AstraZeneca Boehringer Chiesi NAPP Nutricia Pfizer